TABLE 3.
Transfer of resistance for cefotaxime and other antimicrobial agents of clinical isolates carrying blaCTX-M
| Transconjugant | Donor strain | Transferred bla gene(s) | MICa (μg/ml)
|
Antimicrobial resistance patternb | ||||
|---|---|---|---|---|---|---|---|---|
| CTX | CAZ | ATM | FEP | FOX | ||||
| P1-1J | 03K892 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 2 | AMP AMK GEN KAN SXT |
| 11-1J | 03K681 | blaCTX-M-3, blaOXA-30 | 128 | 4 | 16 | 16 | 8 | AMP AMK GEN KAN SXT |
| 15-1J | EC25 | blaCTX-M-3 | 64 | <1 | 16 | 8 | 2 | AMP AMK GEN KAN SXT TMP |
| 35-1J | KP7 | blaCTX-M-3 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT TMP |
| 36-1J | KP9 | blaCTX-M-3 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT TMP |
| 34-2J | KP2 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 2 | AMP AMK GEN KAN SXT |
| 34-1J | KP 2 | blaCTX-M-3, blaSHV-12, blaDHA-1 | 32 | 16 | 32 | <1 | 32 | AMP AMK GEN KAN CHL STR SXT |
| 24-1J | 03K839 | blaCTX-M-3, blaOXA-30, blaTEM-1 | 128 | 16 | 32 | 8 | 4 | AMP GEN KAN SXT TMP |
| 38-1J | 03K188 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT |
| 39-1J | 03K196 | blaCTX-M-3, blaOXA-30 | 64 | <1 | 8 | 4 | 4 | AMP AMK GEN KAN SXT |
| 40-1J | 03K201 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT |
| 41-1J | 03K205 | blaCTX-M-3, blaOXA-30 | 32 | 2 | 16 | 8 | 8 | AMP AMK GEN KAN SXT |
| 37-1J | 03K168 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT |
| 43-1J | 03K921 | blaCTX-M-3 | 32 | 2 | 8 | 32 | 2 | AMP KAN STR |
| 44-1J | 03K980 | blaCTX-M-3 | 4 | 2 | 8 | 32 | 4 | AMP AMK KAN STR |
| 45-1J | SM 16 | blaCTX-M-3 | 4 | 2 | 16 | 32 | 8 | AMP AMK GEN KAN STR SXT TMP |
| 46-1J | SM 3 | blaCTX-M-3 | 8 | 2 | 16 | 16 | 8 | AMP AMK GEN KAN STR SXT TMP |
| 13-1J | 03K865 | blaCTX-M-15 | 128 | <1 | 8 | 2 | 4 | AMP |
| 14-1J | 03K969 | blaCTX-M-15, blaOXA-30, blaTEM-1 | 512 | 8 | 16 | 8 | 4 | AMP SXT TMP |
| 20-1J | J144 | blaCTX-M-15 | 256 | 8 | 16 | 8 | 4 | AMP SXT |
| 22-1J | J159 | blaCTX-M-15 | 128 | <1 | 4 | 8 | 32 | AMP |
| 19-1J | J133 | blaCTX-M-15, blaTEM-54 | 256 | 4 | 16 | 4 | 4 | AMP |
| 06-1J | J187 | blaCTX-M-9 | 8 | <1 | 2 | 2 | 32 | AMP CHL TET SXT TMP |
| 05-1J | 03K42 | blaCTX-M-9, blaSHV-12 | 4 | 4 | 8 | <1 | 2 | AMP CHL SXT TMP |
| 09-2J | 03K380 | blaCTX-M-9, blaSHV-12 | 8 | 64 | 64 | <1 | 2 | AMP CHL SXT TMP |
| 18-1J | 18-1J | blaCTX-M-14, blaOXA-30, blaTEM-1 | 512 | 2 | 8 | 16 | 4 | AMP TET STR SXT |
| 16-1J | EC27 | blaCTX-M-14 | 128 | 2 | 16 | 16 | 8 | AMP |
| 23-1J | J167 | blaCTX-M-14 | 64 | <1 | 8 | 8 | 8 | AMP STR SXT |
| 25-1J | 03K930 | blaCTX-M-14 | 64 | <1 | 2 | 4 | 4 | AMP STR SXT |
| E. coli J53 AzideR recipient | <1 | <1 | <1 | <1 | 4 | |||
MIC as determined by the agar dilution method. Abbreviations: CTX, cefotaxime; CAZ, ceftazidime; ATM, aztreonam; FEP, cefepime; FOX, cefoxitin.
Abbreviations: AMP, ampicillin; CHL, chloramphenicol; TET, tetracycline; STR, streptomycin; SXT, sulfisoxazole; TMP, trimethoprim; KAN, kanamycin; GEN, gentamicin; AMK, amikacin.